Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lison

Showing results (491-500 of 505) with videos related to

Pageof 51
Sort By:
Molecular Therapy. Nucleic Acids|December 6, 2024
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomasPedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Vaccine|September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccineEunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
International Journal of Epidemiology|March 25, 2022
Excess risk of subsequent infection in hospitalized children from a community cohort study in Cambodia and MadagascarLison Rambliere, Elsa Kermorvant-Duchemin, Agathe de Lauzanne, et al.
Journal of Clinical Gastroenterology|August 9, 2017
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or RevisionArmand Garioud, Jean-François Cadranel, Arnaud Pauwels, et al.
BMC Psychiatry|September 19, 2022
Study protocol of a randomized controlled trial evaluating home treatment with peer support for acute mental health crises (HoPe)Britta Reinke, Candelaria Mahlke, Christina Botros, et al.
The American Journal of Gastroenterology|September 14, 2016
The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic OutpatientsThierry Thévenot, Charline Briot, Vincent Macé, et al.
Annals of Hepatology|May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting AntiviralsAlexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Toxicology Letters|June 26, 2016
The European Registered Toxicologist (ERT): Current status and prospects for advancementMartin F Wilks, Bas J Blaauboer, Rolf Schulte-Hermann, et al.
Presse Medicale (Paris, France : 1983)|March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.
Pageof 51

Showing results (491-500 of 505) with videos related to

Sort By:
Pageof 51
Molecular Therapy. Nucleic Acids|December 6, 2024
First-in-class transactivator-free, doxycycline-inducible IL-18-engineered CAR-T cells for relapsed/refractory B cell lymphomasPedro Justicia-Lirio, María Tristán-Manzano, Noelia Maldonado-Pérez, et al.
Vaccine|September 14, 2024
Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccineEunice Y C Shiu, Samuel M S Cheng, Mario Martín-Sánchez, et al.
International Journal of Epidemiology|March 25, 2022
Excess risk of subsequent infection in hospitalized children from a community cohort study in Cambodia and MadagascarLison Rambliere, Elsa Kermorvant-Duchemin, Agathe de Lauzanne, et al.
Journal of Clinical Gastroenterology|August 9, 2017
Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or RevisionArmand Garioud, Jean-François Cadranel, Arnaud Pauwels, et al.
BMC Psychiatry|September 19, 2022
Study protocol of a randomized controlled trial evaluating home treatment with peer support for acute mental health crises (HoPe)Britta Reinke, Candelaria Mahlke, Christina Botros, et al.
The American Journal of Gastroenterology|September 14, 2016
The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic OutpatientsThierry Thévenot, Charline Briot, Vincent Macé, et al.
Annals of Hepatology|May 23, 2019
Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting AntiviralsAlexandre Pariente, Jean-Pierre Arpurt, Andre-Jean Remy, et al.
Toxicology Letters|June 26, 2016
The European Registered Toxicologist (ERT): Current status and prospects for advancementMartin F Wilks, Bas J Blaauboer, Rolf Schulte-Hermann, et al.
Presse Medicale (Paris, France : 1983)|March 12, 2019
Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH)Alexandre Pariente, Jean-Pierre Arpurt, André-Jean Rémy, et al.
The Lancet. Microbe|August 7, 2023
Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trialNancy H L Leung, Samuel M S Cheng, Carolyn A Cohen, et al.
Pageof 51